会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Methods and organisms for utilizing synthesis gas or other gaseous carbon sources and methanol
    • 利用合成气或其他气态碳源和甲醇的方法和生物
    • US09051552B2
    • 2015-06-09
    • US12875068
    • 2010-09-02
    • Mark J. BurkChristophe H. SchillingAnthony P. BurgardJohn D. Trawick
    • Mark J. BurkChristophe H. SchillingAnthony P. BurgardJohn D. Trawick
    • C12N9/20C12N9/10C12N9/02C12N9/00C12P19/32
    • C12P7/18C12N9/0008C12N9/0036C12N9/1007C12N9/93C12N15/70C12P19/32Y02E50/343
    • The invention provides a non-naturally occurring microbial organism having an acetyl-CoA pathway and the capability of utilizing syngas or syngas and methanol. In one embodiment, the invention provides a non-naturally occurring microorganism, comprising one or more exogenous proteins conferring to the microorganism a pathway to convert CO, CO2 and/or H2 to acetyl-coenzyme A (acetyl-CoA), methyl tetrahydrofolate (methyl-THF) or other desired products, wherein the microorganism lacks the ability to convert CO or CO2 and H2 to acetyl-CoA or methyl-THF in the absence of the one or more exogenous proteins. For example, the microbial organism can contain at least one exogenous nucleic acid encoding an enzyme or protein in an acetyl-CoA pathway. The microbial organism is capable of utilizing synthesis gases comprising CO, CO2 and/or H2, alone or in combination with methanol, to produce acetyl-CoA. The invention additionally provides a method for producing acetyl-CoA, for example, by culturing an acetyl-CoA producing microbial organism, where the microbial organism expresses at least one exogenous nucleic acid encoding an acetyl-CoA pathway enzyme or protein in a sufficient amount to produce acetyl-CoA, under conditions and for a sufficient period of time to produce acetyl-CoA.
    • 本发明提供具有乙酰-CoA途径的非天然存在的微生物生物体,以及利用合成气或合成气和甲醇的能力。 在一个实施方案中,本发明提供非天然存在的微生物,其包含一种或多种外源蛋白质,赋予微生物将CO,CO 2和/或H 2转化为乙酰辅酶A(乙酰辅酶A),甲基四氢叶酸(甲基 -THF)或其它所需产物,其中微生物缺乏在不存在一种或多种外源蛋白的情况下将CO或CO 2和H 2转化为乙酰辅酶A或甲基-THF的能力。 例如,微生物生物体可以含有至少一种编码乙酰辅酶A途径中的酶或蛋白质的外源核酸。 微生物生物能够单独或与甲醇组合使用包含CO,CO 2和/或H 2的合成气体,以产生乙酰辅酶A。 本发明另外提供了生产乙酰辅酶A的方法,例如通过培养产生乙酰辅酶A的微生物,其中微生物生物体表达至少一种编码乙酰辅酶A途径酶或蛋白质的外源核酸,其量足够 在条件下和足够的时间内产生乙酰辅酶A产生乙酰辅酶A。
    • 2. 发明授权
    • Multicellular metabolic models and methods
    • US08949032B2
    • 2015-02-03
    • US11188136
    • 2005-07-21
    • Imandokht FamiliChristophe H. Schilling
    • Imandokht FamiliChristophe H. Schilling
    • G01N33/50G06F19/12G06F19/18G06F19/28
    • G06F19/12G01N33/5008G01N2500/10G06F19/18G06F19/28G06F19/704
    • The invention provides a computer readable medium or media, having: (a) a first data structure relating a plurality of reactants to a plurality of reactions from a first cell, each of said reactions comprising a reactant identified as a substrate of the reaction, a reactant identified as a product of the reaction and a stoichiometric coefficient relating said substrate and said product; (b) a second data structure relating a plurality of reactants to a plurality of reactions from a second cell, each of said reactions comprising a reactant identified as a substrate of the reaction, a reactant identified as a product of the reaction and a stoichiometric coefficient relating said substrate and said product; (c) a third data structure relating a plurality of intra-system reactants to a plurality of intra-system reactions between said first and second cells, each of said intra-system reactions comprising a reactant identified as a substrate of the reaction, a reactant identified as a product of the reaction and a stoichiometric coefficient relating said substrate and said product; (d) a constraint set for said plurality of reactions for said first, second and third data structures, and (e) commands for determining at least one flux distribution that minimizes or maximizes an objective function when said constraint set is applied to said first and second data structures, wherein said at least one flux distribution is predictive of a physiological function of said first and second cells. The first, second and third data structures also can include a plurality of data structures. Additionally provided is a method for predicting a physiological function of a multicellular organism. The method includes: (a) providing a first data structure relating a plurality of reactants to a plurality of reactions from a first cell, each of said reactions comprising a reactant identified as a substrate of the reaction, a reactant identified as a product of the reaction and a stoichiometric coefficient relating said substrate and said product; (b) providing a second data structure relating a plurality of reactants to a plurality of reactions from a second cell, each of said reactions comprising a reactant identified as a substrate of the reaction, a reactant identified as a product of the reaction and a stoichiometric coefficient relating said substrate and said product; (c) providing a third data structure relating a plurality of intra-system reactants to a plurality of intra-system reactions between said first and second cells, each of said intra-system reactions comprising a reactant identified as a substrate of the reaction, a reactant identified as a product of the reaction and a stoichiometric coefficient relating said substrate and said product; (d) providing a constraint set for said plurality of reactions for said first, second and third data structures; (e) providing an objective function, and (f) determining at least one flux distribution that minimizes or maximizes an objective function when said constraint set is applied to said first and second data structures, wherein said at least one flux distribution is predictive of a physiological function of said first and second cells.
    • 6. 发明授权
    • Systems and methods for constructing genomic-based phenotypic models
    • 用于构建基因组型表型模型的系统和方法
    • US08301430B2
    • 2012-10-30
    • US12947814
    • 2010-11-16
    • Christophe H. Schilling
    • Christophe H. Schilling
    • G06G7/58
    • G06F19/12
    • The invention provides a computer implemented process for constructing a scalable output network model of a bioparticle. The process includes computer implemented steps of: (a) accessing a database of network gene components including an annotated network set of open reading frames (ORFs) of a bioparticle genome; (b) forming a data structure associating the network gene components with network reaction components, the data structure establishing a data set specifying a network model of connectivity and flow of the network reaction components, and (c) transforming the data set into a mathematical description of reactant fluxes defining the network model of connectivity and flow, wherein the mathematical description defines a scalable output network model of a bioparticle.
    • 本发明提供了一种用于构建生物颗粒的可伸缩输出网络模型的计算机实现过程。 该过程包括计算机实现的步骤:(a)访问网络基因组件的数据库,包括生物颗粒基因组的开放阅读框(ORF)的注释网络集合; (b)形成将网络基因组件与网络反应组件相关联的数据结构,建立指定网络反应组件的连通性和流量的网络模型的数据集的数据结构,以及(c)将数据集转换为数学描述 反应物通量定义了连通性和流量的网络模型,其中数学描述定义了生物颗粒的可伸缩输出网络模型。
    • 7. 发明授权
    • Human metabolic models and methods
    • 人类代谢模型和方法
    • US08229673B2
    • 2012-07-24
    • US10402854
    • 2003-03-27
    • Bornhard O. PalssonImandokht FamiliMarkus W. CovertChristophe H. Schilling
    • Bornhard O. PalssonImandokht FamiliMarkus W. CovertChristophe H. Schilling
    • G01N33/50G01N33/48
    • G06F19/12G06F19/18G06F19/28
    • The invention provides in silico models for determining the physiological function of human cells, including human skeletal muscle cells. The models include a data structure relating a plurality of Homo sapiens reactants to a plurality of Homo sapiens reactions, a constraint set for the plurality of Homo sapiens reactions, and commands for determining a distribution of flux through the reactions that is predictive of a Homo sapiens physiological function. A model of the invention can further include a gene database containing information characterizing the associated gene or genes. A regulated Homo sapiens reaction can be represented in a model of the invention by including a variable constraint for the regulated reaction. The invention further provides methods for making an in silico Homo sapiens model and methods for determining a Homo sapiens physiological function using a model of the invention.
    • 本发明提供了用于确定人类细胞(包括人类骨骼肌细胞)的生理功能的计算机模型。 这些模型包括将多个智人反应物与多个智人反应相关联的数据结构,针对多个智人反应的约束集,以及用于确定通过反应的通量分布的命令,该反应预测人 生理功能。 本发明的模型还可以包括含有表征相关基因或基因的信息的基因数据库。 调节的智人反应可以通过包括调节反应的可变约束在本发明的模型中表示。 本发明还提供了使用本发明的模型制备计算机智人模型和用于确定智人生理功能的方法。
    • 9. 发明授权
    • Systems and methods for constructing genomic-based phenotypic models
    • 用于构建基因组型表型模型的系统和方法
    • US07856317B2
    • 2010-12-21
    • US10173547
    • 2002-06-14
    • Christophe H. Schilling
    • Christophe H. Schilling
    • G01N33/48
    • G06F19/12
    • The invention provides a computer implemented process for constructing a scalable output network model of a bioparticle. The process includes computer implemented steps of: (a) accessing a database of network gene components including an annotated network set of open reading frames (ORFs) of a bioparticle genome; (b) forming a data structure associating the network gene components with network reaction components, the data structure establishing a data set specifying a network model of connectivity and flow of the network reaction components, and (c) transforming the data set into a mathematical description of reactant fluxes defining the network model of connectivity and flow, wherein the mathematical description defines a scalable output network model of a bioparticle.
    • 本发明提供了一种用于构建生物颗粒的可伸缩输出网络模型的计算机实现过程。 该过程包括计算机实现的步骤:(a)访问网络基因组件的数据库,包括生物颗粒基因组的开放阅读框(ORF)的注释网络集合; (b)形成将网络基因组件与网络反应组件相关联的数据结构,数据结构建立指定网络反应组件的连通性和流程的网络模型的数据集,以及(c)将数据集变换为数学描述 反应物通量定义了连通性和流量的网络模型,其中数学描述定义了生物颗粒的可伸缩输出网络模型。
    • 10. 发明申请
    • COMPLEMENTARY METABOLIZING ORGANISMS AND METHODS OF MAKING SAME
    • US20090023182A1
    • 2009-01-22
    • US11779865
    • 2007-07-18
    • Christophe H. Schilling
    • Christophe H. Schilling
    • C12P39/00C12N1/00
    • C12P39/00C12N1/22C12P5/007C12P7/18C12P7/42C12P7/46C12P23/00
    • The invention provides a non-naturally occurring set of microbial organisms. The set of organisms includes: at least a first constituent complementary metabolizing organism (CMO) exhibiting the ability to metabolize a first carbon substrate and having substantially impaired metabolic capacity for a second carbon substrate, and at least a second constituent complementary metabolizing organism (CMO) exhibiting the ability to metabolize the second carbon substrate and having substantially impaired metabolic capacity for the first carbon substrate, wherein a co-culture of the at least first and second CMOs exhibit simultaneous metabolism of a mixture having the first and second carbon substrates compared to either CMO alone. Simultaneous metabolism of a mixture having first and second carbon substrates can include an enhanced rate of metabolism of the first and second substrates compared to either CMO alone. Also provided is a bioprocess for producing a chemical compound. The bioprocess includes co-culturing a non-naturally occurring set of microbial organisms in a mixture having at least a first and a second carbon substrate under conditions sufficient for biosynthesis of a target chemical compound, the set of non-naturally occurring microbial organisms including: at least a first constituent complementary metabolizing organism (CMO) exhibiting the ability to metabolize the first carbon substrate and having substantially impaired metabolic capacity for the second carbon substrate, and at least a second constituent complementary metabolizing organism (CMO) exhibiting the ability to metabolize the second carbon substrate and having substantially impaired metabolic capacity for the first carbon substrate, wherein a co-culture of the at least first and second CMOs exhibit simultaneous metabolism of a mixture having the first and second carbon substrates compared to either CMO alone. Simultaneous metabolism of a mixture having first and second carbon substrates can include an enhanced rate of metabolism of the first and second substrates compared to either CMO alone.